Hostname: page-component-848d4c4894-ttngx Total loading time: 0 Render date: 2024-05-19T15:58:05.327Z Has data issue: false hasContentIssue false

Interpreting neuropsychological impairment among adolescent inhalant users: two case reports

Published online by Cambridge University Press:  24 June 2014

Michael J. Takagi
Affiliation:
ORYGEN Research Centre, Department of Psychiatry, The University of Melbourne, Victoria, Australia
Dan I. Lubman
Affiliation:
ORYGEN Research Centre, Department of Psychiatry, The University of Melbourne, Victoria, Australia
Murat Yücel*
Affiliation:
ORYGEN Research Centre, Department of Psychiatry, The University of Melbourne, Victoria, Australia Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne & Melbourne Health, Victoria, Australia
*
Dr Murat Yücel, ORYGEN Research Centre, 35 Poplar Road (Locked Bag 10), Parkville, Victoria 3052, Australia. Tel: +613 9342 2800; Fax: +613 9348 0469; E-mail: murat@unimelb.edu.au

Abstract

Objective:

To illustrate the need to carefully consider mental health, psychosocial and motivational factors when investigating cognitive and intellectual impairment among chronic inhalant users.

Methods:

Two adolescent chronic inhalant users with similar psychosocial disadvantages (eg unstable and dysfunctional families, state-based care, school absenteeism and forensic issues) and histories of comorbid drug use and mental health problems were assessed using a battery of paper and pencil and computerised neuropsychological tests.

Results:

Contrary to the expectations of her case manager, one participant performed within the normal range for her age in all domains of intellectual ability, while the other participant, in line with the expectations of her case manger, showed marked cognitive deficits and intellectual disability.

Conclusions:

The typically complex presentation of chronic inhalant users (ie disadvantaged psychosocial backgrounds, comorbid psychopathology and poor motivation/engagement) is rarely considered when investigating associated cognitive and intellectual functioning. Future research should more carefully consider the role of such factors, given the evidence suggesting that they can considerably alter (accentuate or diminish) the association between inhalant abuse and neuropsychological impairment.

Type
Case report
Copyright
Copyright © 2007 Blackwell Munksgaard

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Rosenberg, N, Grigsby, J, Dreisbach, J, Busenbark, D, Grigsby, P. Neuropsychologic impairment and MRI abnormalities associated with chronic solvent abuse. Clin Toxicol 2002;40:2134. Google ScholarPubMed
Verdejo-Garcia, A, Bechara, A, Recknor, E, Perez-Garcia, M. Executive dysfunction in substance dependent individuals during drug use and abstinence: an examination of the behavioral, cognitive and emotional correlates of addiction. J Int Neuropsychol Soc 2006;12:405415. CrossRefGoogle Scholar
Chadwick, O, Anderson, HR. Neuropsychological consequences of volatile substance abuse: a review. Hum Toxicol 1989;8:307312. CrossRefGoogle ScholarPubMed
Lubman, DI, Yucel, M, Hall, WD. Substances and the adolescent brain: a toxic combination? J Psychopharmacol (in press).Google Scholar
Carroll, A, Houghton, S, Odgers, P. Volatile substance use among Western Australian adolescents. Adolescence 1998;33:877890. Google Scholar
Oetting, ER, Webb, J. Psychosocial characteristics and their links with inhalants: a research agenda. In: Sharp, CW, Beauvais, F, Spence, R, eds. Inhalant abuse: a volatile research agenda. Rockville: National Institute on Drug Abuse, 1992: 5998. Google Scholar
Chadwick, O, Anderson, R, Bland, M, Ramsey, J. Neuropsychological consequences of volatile substance abuse: a population based study of secondary school pupils. BMJ 1989;298:16791684. CrossRefGoogle ScholarPubMed
Lubman, D, Hides, L, Yucel, M. Inhalant misuse in youth: time for a coordinated response. Med J Aust 2006;185:327330. Google ScholarPubMed
Jumper-Thurman, P, Beauvais, F. Treatment of volatile solvent abusers. In: Sharp, CW, Beauvais, F, Spence, R, eds. Inhalant abuse: a volatile research agenda. Rockville: National Institute on Drug Abuse, 1992: 203214. Google Scholar